Form S-1 Invea Therapeutics, Inc
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Invea Therapeutics (INAI) files for proposed IPO
December 15, 2025 6:19 AM EST(Updated - December 15, 2025 6:20 AM EST)
Invea Therapeutics (INAI) has filed for a proposed Nasdaq IPO.
The company describes itself as: "We are a biotechnology company seeking to develop oral, small-molecule therapies for immune-mediated inflammatory diseases, or IMIDs. IMIDs are a diverse group of conditions including skin or cutaneous... More
